SlideShare a Scribd company logo

Skills interpreting data, understanding policy responses, communicating to the public/patient

•Download as PPT, PDF•
•
M
MeTApresents

'Skills – interpreting data, understanding policy responses, communicating to the public/patient', presentation by Kweku Rockson and Alex Dodoo during MeTA Ghana, CSO & media orientation workshop, 16 April 2009.

Health & MedicineBusiness
1 of 15
Skills – interpreting data, understanding policy responses, communicating to the public/patient Kweku Rockson and Alex Dodoo MeTA CSO/Media Orientation 16 th April 2009
Overview ,[object Object],[object Object],[object Object],MeTA CSO Training 16th April 2009
Interpreting data - I ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],MeTA CSO Training 16th April 2009
Interpreting data - II ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],MeTA CSO Training 16th April 2009
Understanding policy responses ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],MeTA CSO Training 16th April 2009
How are policies developed? ,[object Object],[object Object],[object Object],[object Object],[object Object],MeTA CSO Training 16th April 2009
The Malaria Example - I ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],MeTA CSO Training 16th April 2009
The Malaria Example - II ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],MeTA CSO Training 16th April 2009
The Malaria Example - III ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],MeTA CSO Training 16th April 2009
Communicating with the public and patients ,[object Object],[object Object],[object Object],MeTA CSO Training 16th April 2009
Challenges Facing Patients - I ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],MeTA CSO Training 16th April 2009
Challenges Facing Patients - II ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],MeTA CSO Training 16th April 2009
How can health professionals communicate with the public ,[object Object],[object Object],[object Object],[object Object],MeTA CSO Training 16th April 2009
Television Programmes ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],MeTA CSO Training 16th April 2009
Other examples ,[object Object],[object Object],[object Object],MeTA CSO Training 16th April 2009

Recommended

FDA Social Media Guidelines - Introduction
FDA Social Media Guidelines - IntroductionFDA Social Media Guidelines - Introduction
FDA Social Media Guidelines - IntroductionUniversity of Michigan Taubman Health Sciences Library
 
G1 report from breakout group 1
G1 report from breakout group 1G1 report from breakout group 1
G1 report from breakout group 1EUPATI
 
Introduction to the workshop and EUPATI update
Introduction to the workshop and EUPATI updateIntroduction to the workshop and EUPATI update
Introduction to the workshop and EUPATI updateEUPATI
 
Communication & social media
Communication & social media Communication & social media
Communication & social media EUPATI
 
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"EURORDIS - Rare Diseases Europe
 
IMI Graham Hughes
IMI Graham HughesIMI Graham Hughes
IMI Graham HughesCK Group
 
Future Health Summit - Dr Derick Mitchell - May 26th 2016
Future Health Summit - Dr Derick Mitchell - May 26th 2016Future Health Summit - Dr Derick Mitchell - May 26th 2016
Future Health Summit - Dr Derick Mitchell - May 26th 2016ipposi
 
Concept and structure of MeTA
Concept and structure of MeTAConcept and structure of MeTA
Concept and structure of MeTAMeTApresents
 

Recommended

FDA Social Media Guidelines - Introduction
FDA Social Media Guidelines - IntroductionFDA Social Media Guidelines - Introduction
FDA Social Media Guidelines - IntroductionUniversity of Michigan Taubman Health Sciences Library
 
G1 report from breakout group 1
G1 report from breakout group 1G1 report from breakout group 1
G1 report from breakout group 1EUPATI
 
Introduction to the workshop and EUPATI update
Introduction to the workshop and EUPATI updateIntroduction to the workshop and EUPATI update
Introduction to the workshop and EUPATI updateEUPATI
 
Communication & social media
Communication & social media Communication & social media
Communication & social media EUPATI
 
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"EURORDIS - Rare Diseases Europe
 
IMI Graham Hughes
IMI Graham HughesIMI Graham Hughes
IMI Graham HughesCK Group
 
Future Health Summit - Dr Derick Mitchell - May 26th 2016
Future Health Summit - Dr Derick Mitchell - May 26th 2016Future Health Summit - Dr Derick Mitchell - May 26th 2016
Future Health Summit - Dr Derick Mitchell - May 26th 2016ipposi
 
Concept and structure of MeTA
Concept and structure of MeTAConcept and structure of MeTA
Concept and structure of MeTAMeTApresents
 
Derick mitchell, IPPOSI
Derick mitchell, IPPOSIDerick mitchell, IPPOSI
Derick mitchell, IPPOSIInvestnet
 
G2 report from breakout group 2
G2 report from breakout group 2G2 report from breakout group 2
G2 report from breakout group 2EUPATI
 
Workshop 4 - "EURORDIS Research Policy recommendation"
Workshop 4 - "EURORDIS Research Policy recommendation"Workshop 4 - "EURORDIS Research Policy recommendation"
Workshop 4 - "EURORDIS Research Policy recommendation"EURORDIS - Rare Diseases Europe
 
EuroBioForum 2013 - Day 1 | Emmanuelle Benzimra
EuroBioForum 2013 - Day 1 | Emmanuelle BenzimraEuroBioForum 2013 - Day 1 | Emmanuelle Benzimra
EuroBioForum 2013 - Day 1 | Emmanuelle BenzimraEuroBioForum
 
Managing knowledge and relationship by web to improve sales efficacy - SFE Su...
Managing knowledge and relationship by web to improve sales efficacy - SFE Su...Managing knowledge and relationship by web to improve sales efficacy - SFE Su...
Managing knowledge and relationship by web to improve sales efficacy - SFE Su...USP e Plexus
 
EUPATI patient expert training course and its relevance for patient involvement
EUPATI patient expert training course and its relevance for patient involvementEUPATI patient expert training course and its relevance for patient involvement
EUPATI patient expert training course and its relevance for patient involvementEUPATI
 
Open government platforms U.S. federal government
Open government platforms U.S. federal governmentOpen government platforms U.S. federal government
Open government platforms U.S. federal governmentInes Mergel
 
Workshop 7 - "Folic acid prevents neural tubes defect"
Workshop 7 - "Folic acid prevents neural tubes defect"Workshop 7 - "Folic acid prevents neural tubes defect"
Workshop 7 - "Folic acid prevents neural tubes defect"EURORDIS - Rare Diseases Europe
 
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...EUPATI
 
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI
 
ThinkDigital 2010 Research
ThinkDigital 2010 ResearchThinkDigital 2010 Research
ThinkDigital 2010 ResearchDigitas Health LifeBrands
 
JHU-GmI Seminar - Dr. Larry W. Chang
JHU-GmI Seminar - Dr. Larry W. Chang JHU-GmI Seminar - Dr. Larry W. Chang
JHU-GmI Seminar - Dr. Larry W. Chang Johns Hopkins
 
G4 report from breakout group 4
G4 report from breakout group 4G4 report from breakout group 4
G4 report from breakout group 4EUPATI
 
Workshop 7 - "Presentation of the International Federation for Spina Bifida a...
Workshop 7 - "Presentation of the International Federation for Spina Bifida a...Workshop 7 - "Presentation of the International Federation for Spina Bifida a...
Workshop 7 - "Presentation of the International Federation for Spina Bifida a...EURORDIS - Rare Diseases Europe
 
Workshop 4 - "Feedback from the 15 National Conferences on Research policy"
Workshop 4 - "Feedback from the 15 National Conferences on Research policy"Workshop 4 - "Feedback from the 15 National Conferences on Research policy"
Workshop 4 - "Feedback from the 15 National Conferences on Research policy"EURORDIS - Rare Diseases Europe
 
Joint Rare Diseases / Orphan Medicinal Products Task Force
Joint Rare Diseases / Orphan Medicinal Products Task ForceJoint Rare Diseases / Orphan Medicinal Products Task Force
Joint Rare Diseases / Orphan Medicinal Products Task ForceDutch Orphan Drug Network
 
ASCO 2013 Social #HCP Findings for Melanoma - Sample
ASCO 2013 Social #HCP Findings for Melanoma - SampleASCO 2013 Social #HCP Findings for Melanoma - Sample
ASCO 2013 Social #HCP Findings for Melanoma - SampleSteven Wardell
 
Workshop 6 - "Feedback from the 15 National Conferences"
Workshop 6 - "Feedback from the 15 National Conferences"Workshop 6 - "Feedback from the 15 National Conferences"
Workshop 6 - "Feedback from the 15 National Conferences"EURORDIS - Rare Diseases Europe
 
PPI Conference Galway - Dr Derick Mitchell - April 27th 2016
PPI Conference Galway - Dr Derick Mitchell - April 27th 2016PPI Conference Galway - Dr Derick Mitchell - April 27th 2016
PPI Conference Galway - Dr Derick Mitchell - April 27th 2016ipposi
 
Workshop 6 - "BURQOL-RD"
Workshop 6 - "BURQOL-RD"Workshop 6 - "BURQOL-RD"
Workshop 6 - "BURQOL-RD"EURORDIS - Rare Diseases Europe
 
Interpreting the Data:Parallel Analysis with Sawzall
Interpreting the Data:Parallel Analysis with SawzallInterpreting the Data:Parallel Analysis with Sawzall
Interpreting the Data:Parallel Analysis with SawzallTilani Gunawardena PhD(UNIBAS), BSc(Pera), FHEA(UK), CEng, MIESL
 
Analysing and interpreting data
Analysing and interpreting dataAnalysing and interpreting data
Analysing and interpreting dataMuhammad Absor
 

More Related Content

What's hot

Derick mitchell, IPPOSI
Derick mitchell, IPPOSIDerick mitchell, IPPOSI
Derick mitchell, IPPOSIInvestnet
 
G2 report from breakout group 2
G2 report from breakout group 2G2 report from breakout group 2
G2 report from breakout group 2EUPATI
 
EuroBioForum 2013 - Day 1 | Emmanuelle Benzimra
EuroBioForum 2013 - Day 1 | Emmanuelle BenzimraEuroBioForum 2013 - Day 1 | Emmanuelle Benzimra
EuroBioForum 2013 - Day 1 | Emmanuelle BenzimraEuroBioForum
 
Managing knowledge and relationship by web to improve sales efficacy - SFE Su...
Managing knowledge and relationship by web to improve sales efficacy - SFE Su...Managing knowledge and relationship by web to improve sales efficacy - SFE Su...
Managing knowledge and relationship by web to improve sales efficacy - SFE Su...USP e Plexus
 
EUPATI patient expert training course and its relevance for patient involvement
EUPATI patient expert training course and its relevance for patient involvementEUPATI patient expert training course and its relevance for patient involvement
EUPATI patient expert training course and its relevance for patient involvementEUPATI
 
Open government platforms U.S. federal government
Open government platforms U.S. federal governmentOpen government platforms U.S. federal government
Open government platforms U.S. federal governmentInes Mergel
 
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...EUPATI
 
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI
 
JHU-GmI Seminar - Dr. Larry W. Chang
JHU-GmI Seminar - Dr. Larry W. Chang JHU-GmI Seminar - Dr. Larry W. Chang
JHU-GmI Seminar - Dr. Larry W. Chang Johns Hopkins
 
G4 report from breakout group 4
G4 report from breakout group 4G4 report from breakout group 4
G4 report from breakout group 4EUPATI
 
Workshop 7 - "Presentation of the International Federation for Spina Bifida a...
Workshop 7 - "Presentation of the International Federation for Spina Bifida a...Workshop 7 - "Presentation of the International Federation for Spina Bifida a...
Workshop 7 - "Presentation of the International Federation for Spina Bifida a...EURORDIS - Rare Diseases Europe
 
Workshop 4 - "Feedback from the 15 National Conferences on Research policy"
Workshop 4 - "Feedback from the 15 National Conferences on Research policy"Workshop 4 - "Feedback from the 15 National Conferences on Research policy"
Workshop 4 - "Feedback from the 15 National Conferences on Research policy"EURORDIS - Rare Diseases Europe
 
Joint Rare Diseases / Orphan Medicinal Products Task Force
Joint Rare Diseases / Orphan Medicinal Products Task ForceJoint Rare Diseases / Orphan Medicinal Products Task Force
Joint Rare Diseases / Orphan Medicinal Products Task ForceDutch Orphan Drug Network
 
ASCO 2013 Social #HCP Findings for Melanoma - Sample
ASCO 2013 Social #HCP Findings for Melanoma - SampleASCO 2013 Social #HCP Findings for Melanoma - Sample
ASCO 2013 Social #HCP Findings for Melanoma - SampleSteven Wardell
 
Workshop 6 - "Feedback from the 15 National Conferences"
Workshop 6 - "Feedback from the 15 National Conferences"Workshop 6 - "Feedback from the 15 National Conferences"
Workshop 6 - "Feedback from the 15 National Conferences"EURORDIS - Rare Diseases Europe
 
PPI Conference Galway - Dr Derick Mitchell - April 27th 2016
PPI Conference Galway - Dr Derick Mitchell - April 27th 2016PPI Conference Galway - Dr Derick Mitchell - April 27th 2016
PPI Conference Galway - Dr Derick Mitchell - April 27th 2016ipposi
 

What's hot (20)

Derick mitchell, IPPOSI
Derick mitchell, IPPOSIDerick mitchell, IPPOSI
Derick mitchell, IPPOSI
 
G2 report from breakout group 2
G2 report from breakout group 2G2 report from breakout group 2
G2 report from breakout group 2
 
Workshop 4 - "EURORDIS Research Policy recommendation"
Workshop 4 - "EURORDIS Research Policy recommendation"Workshop 4 - "EURORDIS Research Policy recommendation"
Workshop 4 - "EURORDIS Research Policy recommendation"
 
EuroBioForum 2013 - Day 1 | Emmanuelle Benzimra
EuroBioForum 2013 - Day 1 | Emmanuelle BenzimraEuroBioForum 2013 - Day 1 | Emmanuelle Benzimra
EuroBioForum 2013 - Day 1 | Emmanuelle Benzimra
 
Managing knowledge and relationship by web to improve sales efficacy - SFE Su...
Managing knowledge and relationship by web to improve sales efficacy - SFE Su...Managing knowledge and relationship by web to improve sales efficacy - SFE Su...
Managing knowledge and relationship by web to improve sales efficacy - SFE Su...
 
EUPATI patient expert training course and its relevance for patient involvement
EUPATI patient expert training course and its relevance for patient involvementEUPATI patient expert training course and its relevance for patient involvement
EUPATI patient expert training course and its relevance for patient involvement
 
Open government platforms U.S. federal government
Open government platforms U.S. federal governmentOpen government platforms U.S. federal government
Open government platforms U.S. federal government
 
Workshop 7 - "Folic acid prevents neural tubes defect"
Workshop 7 - "Folic acid prevents neural tubes defect"Workshop 7 - "Folic acid prevents neural tubes defect"
Workshop 7 - "Folic acid prevents neural tubes defect"
 
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
 
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
 
ThinkDigital 2010 Research
ThinkDigital 2010 ResearchThinkDigital 2010 Research
ThinkDigital 2010 Research
 
JHU-GmI Seminar - Dr. Larry W. Chang
JHU-GmI Seminar - Dr. Larry W. Chang JHU-GmI Seminar - Dr. Larry W. Chang
JHU-GmI Seminar - Dr. Larry W. Chang
 
G4 report from breakout group 4
G4 report from breakout group 4G4 report from breakout group 4
G4 report from breakout group 4
 
Workshop 7 - "Presentation of the International Federation for Spina Bifida a...
Workshop 7 - "Presentation of the International Federation for Spina Bifida a...Workshop 7 - "Presentation of the International Federation for Spina Bifida a...
Workshop 7 - "Presentation of the International Federation for Spina Bifida a...
 
Workshop 4 - "Feedback from the 15 National Conferences on Research policy"
Workshop 4 - "Feedback from the 15 National Conferences on Research policy"Workshop 4 - "Feedback from the 15 National Conferences on Research policy"
Workshop 4 - "Feedback from the 15 National Conferences on Research policy"
 
Joint Rare Diseases / Orphan Medicinal Products Task Force
Joint Rare Diseases / Orphan Medicinal Products Task ForceJoint Rare Diseases / Orphan Medicinal Products Task Force
Joint Rare Diseases / Orphan Medicinal Products Task Force
 
ASCO 2013 Social #HCP Findings for Melanoma - Sample
ASCO 2013 Social #HCP Findings for Melanoma - SampleASCO 2013 Social #HCP Findings for Melanoma - Sample
ASCO 2013 Social #HCP Findings for Melanoma - Sample
 
Workshop 6 - "Feedback from the 15 National Conferences"
Workshop 6 - "Feedback from the 15 National Conferences"Workshop 6 - "Feedback from the 15 National Conferences"
Workshop 6 - "Feedback from the 15 National Conferences"
 
PPI Conference Galway - Dr Derick Mitchell - April 27th 2016
PPI Conference Galway - Dr Derick Mitchell - April 27th 2016PPI Conference Galway - Dr Derick Mitchell - April 27th 2016
PPI Conference Galway - Dr Derick Mitchell - April 27th 2016
 
Workshop 6 - "BURQOL-RD"
Workshop 6 - "BURQOL-RD"Workshop 6 - "BURQOL-RD"
Workshop 6 - "BURQOL-RD"
 

Viewers also liked

Analysing and interpreting data
Analysing and interpreting dataAnalysing and interpreting data
Analysing and interpreting dataMuhammad Absor
 
Drawings, Tables, Graphs
Drawings, Tables, GraphsDrawings, Tables, Graphs
Drawings, Tables, GraphsDwayne Squires
 
Modern Manufacturing: 4 Ways Data is Transforming the Industry
Modern Manufacturing: 4 Ways Data is Transforming the IndustryModern Manufacturing: 4 Ways Data is Transforming the Industry
Modern Manufacturing: 4 Ways Data is Transforming the IndustryTableau Software
 
Using Spss Transforming Variable - Compute
Using Spss Transforming Variable - ComputeUsing Spss Transforming Variable - Compute
Using Spss Transforming Variable - ComputeDr Ali Yusob Md Zain
 
Collecting, analyzing and interpreting data
Collecting, analyzing and interpreting dataCollecting, analyzing and interpreting data
Collecting, analyzing and interpreting dataJimi Kayode
 
Formal Report Assignment
Formal Report AssignmentFormal Report Assignment
Formal Report AssignmentPaul FitzGerald
 
report on project paper
report on project paperreport on project paper
report on project paperSeredup Maya
 
Components Of Formal Report
Components Of Formal ReportComponents Of Formal Report
Components Of Formal ReportImran Udas
 
List of Useful Words for Interpreting Data in the IELTS Writing Test
List of Useful Words for Interpreting Data in the IELTS Writing TestList of Useful Words for Interpreting Data in the IELTS Writing Test
List of Useful Words for Interpreting Data in the IELTS Writing TestJROOZ Review Center
 
Presentation and analysis and interpretation of data
Presentation and analysis and interpretation of dataPresentation and analysis and interpretation of data
Presentation and analysis and interpretation of dataLovely Ann Azanza
 

Viewers also liked (11)

Interpreting the Data:Parallel Analysis with Sawzall
Interpreting the Data:Parallel Analysis with SawzallInterpreting the Data:Parallel Analysis with Sawzall
Interpreting the Data:Parallel Analysis with Sawzall
 
Analysing and interpreting data
Analysing and interpreting dataAnalysing and interpreting data
Analysing and interpreting data
 
Drawings, Tables, Graphs
Drawings, Tables, GraphsDrawings, Tables, Graphs
Drawings, Tables, Graphs
 
Modern Manufacturing: 4 Ways Data is Transforming the Industry
Modern Manufacturing: 4 Ways Data is Transforming the IndustryModern Manufacturing: 4 Ways Data is Transforming the Industry
Modern Manufacturing: 4 Ways Data is Transforming the Industry
 
Using Spss Transforming Variable - Compute
Using Spss Transforming Variable - ComputeUsing Spss Transforming Variable - Compute
Using Spss Transforming Variable - Compute
 
Collecting, analyzing and interpreting data
Collecting, analyzing and interpreting dataCollecting, analyzing and interpreting data
Collecting, analyzing and interpreting data
 
Formal Report Assignment
Formal Report AssignmentFormal Report Assignment
Formal Report Assignment
 
report on project paper
report on project paperreport on project paper
report on project paper
 
Components Of Formal Report
Components Of Formal ReportComponents Of Formal Report
Components Of Formal Report
 
List of Useful Words for Interpreting Data in the IELTS Writing Test
List of Useful Words for Interpreting Data in the IELTS Writing TestList of Useful Words for Interpreting Data in the IELTS Writing Test
List of Useful Words for Interpreting Data in the IELTS Writing Test
 
Presentation and analysis and interpretation of data
Presentation and analysis and interpretation of dataPresentation and analysis and interpretation of data
Presentation and analysis and interpretation of data
 

Similar to Skills interpreting data, understanding policy responses, communicating to the public/patient

Ilaria passarani - Selling Sickness 2010
Ilaria passarani - Selling Sickness 2010Ilaria passarani - Selling Sickness 2010
Ilaria passarani - Selling Sickness 2010Gezonde scepsis
 
Pharma, Social Media, & Mobile A Happy Ménage à Trois?
Pharma, Social Media, & Mobile A Happy Ménage à Trois?Pharma, Social Media, & Mobile A Happy Ménage à Trois?
Pharma, Social Media, & Mobile A Happy Ménage à Trois?Pharma Guy
 
EPAF final
EPAF finalEPAF final
EPAF finalFEChair
 
Social Media In Pharmaceuticals Acg
Social Media In Pharmaceuticals AcgSocial Media In Pharmaceuticals Acg
Social Media In Pharmaceuticals AcgRajaramiyer
 
Business and Healthcare
Business and HealthcareBusiness and Healthcare
Business and Healthcarereachjoemar
 
Orphan Drugs – High Prices: Is there a Way Forward?
Orphan Drugs – High Prices: Is there a Way Forward?Orphan Drugs – High Prices: Is there a Way Forward?
Orphan Drugs – High Prices: Is there a Way Forward?Office of Health Economics
 
Polypharmacy resource_JAN 15_NINA BARNETT
Polypharmacy resource_JAN 15_NINA BARNETTPolypharmacy resource_JAN 15_NINA BARNETT
Polypharmacy resource_JAN 15_NINA BARNETTZeshan Ahmed
 
HEALTH TECHNOLOGY ASSESSMENT (HTA) IN EUROPE:
HEALTH TECHNOLOGY ASSESSMENT (HTA) IN EUROPE:HEALTH TECHNOLOGY ASSESSMENT (HTA) IN EUROPE:
HEALTH TECHNOLOGY ASSESSMENT (HTA) IN EUROPE:Mohammad Sheikh, MBA
 
EUPATI’s framework on Informing the “health-interested” public about medicine...
EUPATI’s framework on Informing the “health-interested” public about medicine...EUPATI’s framework on Informing the “health-interested” public about medicine...
EUPATI’s framework on Informing the “health-interested” public about medicine...Nowgen
 
Orphan Medicinal Product Designation in the EU - By Compliance Global Inc.
Orphan Medicinal Product Designation in the EU - By Compliance Global Inc.Orphan Medicinal Product Designation in the EU - By Compliance Global Inc.
Orphan Medicinal Product Designation in the EU - By Compliance Global Inc.Compliance Global Inc
 
World Health Day 2011
World Health Day 2011World Health Day 2011
World Health Day 2011mediconerd
 
The data and analytics of the new life sciences marketplace handout
The data and analytics of the new life sciences marketplace handoutThe data and analytics of the new life sciences marketplace handout
The data and analytics of the new life sciences marketplace handoutFrank Wartenberg
 
http://www.lse.ac.uk/LSEHealthAndSocialCare/pdf/eurohealth/Vol14No3/Bond.pdfBond
http://www.lse.ac.uk/LSEHealthAndSocialCare/pdf/eurohealth/Vol14No3/Bond.pdfBondhttp://www.lse.ac.uk/LSEHealthAndSocialCare/pdf/eurohealth/Vol14No3/Bond.pdfBond
http://www.lse.ac.uk/LSEHealthAndSocialCare/pdf/eurohealth/Vol14No3/Bond.pdfBondGeorgi Daskalov
 
Brian Ager - Selling Sickness 2010
Brian Ager - Selling Sickness 2010Brian Ager - Selling Sickness 2010
Brian Ager - Selling Sickness 2010Gezonde scepsis
 

Similar to Skills interpreting data, understanding policy responses, communicating to the public/patient (20)

Ilaria passarani - Selling Sickness 2010
Ilaria passarani - Selling Sickness 2010Ilaria passarani - Selling Sickness 2010
Ilaria passarani - Selling Sickness 2010
 
Pharma, Social Media, & Mobile A Happy Ménage à Trois?
Pharma, Social Media, & Mobile A Happy Ménage à Trois?Pharma, Social Media, & Mobile A Happy Ménage à Trois?
Pharma, Social Media, & Mobile A Happy Ménage à Trois?
 
9a Alves Pharma
9a Alves Pharma9a Alves Pharma
9a Alves Pharma
 
European Policy Audit on Fertility
European Policy Audit on Fertility European Policy Audit on Fertility
European Policy Audit on Fertility
 
EPAF final
EPAF finalEPAF final
EPAF final
 
Social Media In Pharmaceuticals Acg
Social Media In Pharmaceuticals AcgSocial Media In Pharmaceuticals Acg
Social Media In Pharmaceuticals Acg
 
Business and Healthcare
Business and HealthcareBusiness and Healthcare
Business and Healthcare
 
Orphan Drugs – High Prices: Is there a Way Forward?
Orphan Drugs – High Prices: Is there a Way Forward?Orphan Drugs – High Prices: Is there a Way Forward?
Orphan Drugs – High Prices: Is there a Way Forward?
 
Polypharmacy resource_JAN 15_NINA BARNETT
Polypharmacy resource_JAN 15_NINA BARNETTPolypharmacy resource_JAN 15_NINA BARNETT
Polypharmacy resource_JAN 15_NINA BARNETT
 
CSO and MeTA
CSO and MeTACSO and MeTA
CSO and MeTA
 
2013 Romanian legal framework of medically assisted reproduction
2013 Romanian legal framework of medically assisted reproduction2013 Romanian legal framework of medically assisted reproduction
2013 Romanian legal framework of medically assisted reproduction
 
HEALTH TECHNOLOGY ASSESSMENT (HTA) IN EUROPE:
HEALTH TECHNOLOGY ASSESSMENT (HTA) IN EUROPE:HEALTH TECHNOLOGY ASSESSMENT (HTA) IN EUROPE:
HEALTH TECHNOLOGY ASSESSMENT (HTA) IN EUROPE:
 
EUPATI’s framework on Informing the “health-interested” public about medicine...
EUPATI’s framework on Informing the “health-interested” public about medicine...EUPATI’s framework on Informing the “health-interested” public about medicine...
EUPATI’s framework on Informing the “health-interested” public about medicine...
 
Orphan Medicinal Product Designation in the EU - By Compliance Global Inc.
Orphan Medicinal Product Designation in the EU - By Compliance Global Inc.Orphan Medicinal Product Designation in the EU - By Compliance Global Inc.
Orphan Medicinal Product Designation in the EU - By Compliance Global Inc.
 
Whd amr
Whd amrWhd amr
Whd amr
 
World Health Day 2011
World Health Day 2011World Health Day 2011
World Health Day 2011
 
2020 Knowledge Translation Student Award Panel - Courtney Primeau, PhD, Unive...
2020 Knowledge Translation Student Award Panel - Courtney Primeau, PhD, Unive...2020 Knowledge Translation Student Award Panel - Courtney Primeau, PhD, Unive...
2020 Knowledge Translation Student Award Panel - Courtney Primeau, PhD, Unive...
 
The data and analytics of the new life sciences marketplace handout
The data and analytics of the new life sciences marketplace handoutThe data and analytics of the new life sciences marketplace handout
The data and analytics of the new life sciences marketplace handout
 
http://www.lse.ac.uk/LSEHealthAndSocialCare/pdf/eurohealth/Vol14No3/Bond.pdfBond
http://www.lse.ac.uk/LSEHealthAndSocialCare/pdf/eurohealth/Vol14No3/Bond.pdfBondhttp://www.lse.ac.uk/LSEHealthAndSocialCare/pdf/eurohealth/Vol14No3/Bond.pdfBond
http://www.lse.ac.uk/LSEHealthAndSocialCare/pdf/eurohealth/Vol14No3/Bond.pdfBond
 
Brian Ager - Selling Sickness 2010
Brian Ager - Selling Sickness 2010Brian Ager - Selling Sickness 2010
Brian Ager - Selling Sickness 2010
 

More from MeTApresents

MeTA financial systems and reporting
MeTA financial systems and reportingMeTA financial systems and reporting
MeTA financial systems and reportingMeTApresents
 
Priorities and milestones – The Philippines
Priorities and milestones – The PhilippinesPriorities and milestones – The Philippines
Priorities and milestones – The PhilippinesMeTApresents
 
MeTA priorities and milestones in Peru
MeTA priorities and milestones in PeruMeTA priorities and milestones in Peru
MeTA priorities and milestones in PeruMeTApresents
 
Jordan National Priorities And Milestones
Jordan National Priorities And MilestonesJordan National Priorities And Milestones
Jordan National Priorities And MilestonesMeTApresents
 
MeTA Core Principles
MeTA Core PrinciplesMeTA Core Principles
MeTA Core PrinciplesMeTApresents
 
MeTA and data disclosure
MeTA and data disclosureMeTA and data disclosure
MeTA and data disclosureMeTApresents
 
MeTA priorities and milestones in Zambia
MeTA priorities and milestones in ZambiaMeTA priorities and milestones in Zambia
MeTA priorities and milestones in ZambiaMeTApresents
 
Data disclosure in Zambia
Data disclosure in ZambiaData disclosure in Zambia
Data disclosure in ZambiaMeTApresents
 
MeTA priorities and milestones in Uganda
MeTA priorities and milestones in UgandaMeTA priorities and milestones in Uganda
MeTA priorities and milestones in UgandaMeTApresents
 
MeTA programme implementation, monitoring and reporting
MeTA programme implementation, monitoring and reportingMeTA programme implementation, monitoring and reporting
MeTA programme implementation, monitoring and reportingMeTApresents
 
MeTA pilot countries support needs and recommendations
MeTA pilot countries support needs and recommendationsMeTA pilot countries support needs and recommendations
MeTA pilot countries support needs and recommendationsMeTApresents
 
Strengthening multi-stakeholder processes
Strengthening multi-stakeholder processesStrengthening multi-stakeholder processes
Strengthening multi-stakeholder processesMeTApresents
 
Data disclosure in Jordan
Data disclosure in JordanData disclosure in Jordan
Data disclosure in JordanMeTApresents
 
MeTA International priorities and milestones
MeTA International priorities and milestonesMeTA International priorities and milestones
MeTA International priorities and milestonesMeTApresents
 
MeTA priorities and milestones in Ghana
MeTA priorities and milestones in GhanaMeTA priorities and milestones in Ghana
MeTA priorities and milestones in GhanaMeTApresents
 
Data disclosure in Ghana
Data disclosure in GhanaData disclosure in Ghana
Data disclosure in GhanaMeTApresents
 
Data disclosurein Kyrgyzstan
Data disclosurein KyrgyzstanData disclosurein Kyrgyzstan
Data disclosurein KyrgyzstanMeTApresents
 
MeTA evaluation and future
MeTA evaluation and futureMeTA evaluation and future
MeTA evaluation and futureMeTApresents
 
MeTA country guidance note
MeTA country guidance noteMeTA country guidance note
MeTA country guidance noteMeTApresents
 

More from MeTApresents (20)

MeTA financial systems and reporting
MeTA financial systems and reportingMeTA financial systems and reporting
MeTA financial systems and reporting
 
Priorities and milestones – The Philippines
Priorities and milestones – The PhilippinesPriorities and milestones – The Philippines
Priorities and milestones – The Philippines
 
MeTA priorities and milestones in Peru
MeTA priorities and milestones in PeruMeTA priorities and milestones in Peru
MeTA priorities and milestones in Peru
 
Jordan National Priorities And Milestones
Jordan National Priorities And MilestonesJordan National Priorities And Milestones
Jordan National Priorities And Milestones
 
MeTA introduction
MeTA introductionMeTA introduction
MeTA introduction
 
MeTA Core Principles
MeTA Core PrinciplesMeTA Core Principles
MeTA Core Principles
 
MeTA and data disclosure
MeTA and data disclosureMeTA and data disclosure
MeTA and data disclosure
 
MeTA priorities and milestones in Zambia
MeTA priorities and milestones in ZambiaMeTA priorities and milestones in Zambia
MeTA priorities and milestones in Zambia
 
Data disclosure in Zambia
Data disclosure in ZambiaData disclosure in Zambia
Data disclosure in Zambia
 
MeTA priorities and milestones in Uganda
MeTA priorities and milestones in UgandaMeTA priorities and milestones in Uganda
MeTA priorities and milestones in Uganda
 
MeTA programme implementation, monitoring and reporting
MeTA programme implementation, monitoring and reportingMeTA programme implementation, monitoring and reporting
MeTA programme implementation, monitoring and reporting
 
MeTA pilot countries support needs and recommendations
MeTA pilot countries support needs and recommendationsMeTA pilot countries support needs and recommendations
MeTA pilot countries support needs and recommendations
 
Strengthening multi-stakeholder processes
Strengthening multi-stakeholder processesStrengthening multi-stakeholder processes
Strengthening multi-stakeholder processes
 
Data disclosure in Jordan
Data disclosure in JordanData disclosure in Jordan
Data disclosure in Jordan
 
MeTA International priorities and milestones
MeTA International priorities and milestonesMeTA International priorities and milestones
MeTA International priorities and milestones
 
MeTA priorities and milestones in Ghana
MeTA priorities and milestones in GhanaMeTA priorities and milestones in Ghana
MeTA priorities and milestones in Ghana
 
Data disclosure in Ghana
Data disclosure in GhanaData disclosure in Ghana
Data disclosure in Ghana
 
Data disclosurein Kyrgyzstan
Data disclosurein KyrgyzstanData disclosurein Kyrgyzstan
Data disclosurein Kyrgyzstan
 
MeTA evaluation and future
MeTA evaluation and futureMeTA evaluation and future
MeTA evaluation and future
 
MeTA country guidance note
MeTA country guidance noteMeTA country guidance note
MeTA country guidance note
 

Recently uploaded

Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingArunagarwal328757
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxepilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfPULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?bkling
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxDr.Nusrat Tariq
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxvirengeeta
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health: the information environment.pptxThe next social challenge to public health: the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...saminamagar
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfLUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxGlomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 

Recently uploaded (20)

Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, Pricing
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxepilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfPULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptx
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health: the information environment.pptxThe next social challenge to public health: the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfLUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxGlomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 

Skills interpreting data, understanding policy responses, communicating to the public/patient

  • 1. Skills – interpreting data, understanding policy responses, communicating to the public/patient Kweku Rockson and Alex Dodoo MeTA CSO/Media Orientation 16 th April 2009
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.